Assessing the Capabilities of CMOs/CDMOs for Safely Handling Payloads & ADCs for Worker & Product Protection Purposes - 17th World ADC San Diego

Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Assessing the Capabilities of CMOs/CDMOs for Safely Handling Payloads & ADCs for Worker & Product Protection Purposes

11:30 am - Tuesday 13th October 2026

Exploring quantitative risk and exposure assessment development of occupational exposure limits, acceptable surface limits and permitted daily exposures
Undergoing quantitative exposure assessment for worker exposure purposes including validated industrial hygiene air sampling and surface sampling methods
Reviewing extractables and leachables for bioprocess train and container closure systems for patient safety

Speakers:

Janet Gould

Janet Gould

Senior Principal Toxicologist

SafeBridge ® Regulatory & Life Sciences Group